Credit Suisse Maintains Outperform on IQVIA Holdings, Raises Price Target to $265
Credit Suisse analyst Erin Wilson maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $242 to $265.
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning session, 124 stocks hit new 52-week highs.
IQVIA Launches the Clinical Data Analytics Suite to Enable Smarter, Faster Clinical Trials
IQVIA™ (NYSE:IQV) today introduced Clinical Data Analytics Suite (CDAS), a new SaaS-based clinical data analytics platform that combines structured and unstructured data from clinical trials into a single,
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs.
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 125 stocks hit new 52-week highs.
nView Health Announces Multi-year License Agreement With IQVIA
nView Health, the premier provider of evidence-based behavioral health assessment solutions, is pleased to announce that is has executed a multi-year license agreement with IQVIA, one of the world's leading
CORRECTION: Canaccord Genuity Maintains Buy on IQVIA Holdings, Raises Price Target to $260 – The Correct Analyst Firm Is Argus
CORRECTION: Canaccord Genuity Maintains Buy on IQVIA Holdings, Raises Price Target to $260 - The Correct Analyst Firm Is Argus
Canaccord Genuity Maintains Buy on IQVIA Holdings, Raises Price Target to $260
Canaccord Genuity analyst Jasper Hellweg maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $220 to $260.
Earnings Scheduled For April 22, 2021
Companies Reporting Before The Bell
• Republic First Bancorp (NASDAQ:FRBK) is estimated to report quarterly earnings at $0.05 per share on revenue of $36.85 million.